South Africa Orders Urgent Recall of Compounded Weight-Loss Drugs

Africa · Southern Key Facts —The recall. SAHPRA ordered a Class I, Type A recall of compounded semaglutide and tirzepatide products made by iDexis/Sentra Pharmacy. —The warning. Prescribers and pharmacists face fines from R25,000 to R75,000 (about US$1,500–US$4,600) and potential loss of licence. —The court case. Novo Nordisk won an interim High Court order barring…